Sign in
4

Changes in Ownership

abrdn Life Sciences Investors Filed Acc 0001510281-24-000270

10% owner bought 26,526 shares at an average $13.46 ($356,929)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Saba Capital Management, L.P. 10% owner 2024-05-01 Purchase +252 $13.02 $3,281 3,042,456 I: show line 1 in the form
Saba Capital Management, L.P. 10% owner 2024-05-02 Purchase +26,274 $13.46 $353,648 3,068,730 I: show line 2 in the form
Open-market purchases · 26,526 sh · avg $13.46 · $356,929
Loading xslF345X05/primary_doc.xml…